Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (16861)	12/11/1998 3:25:00 PM
From: Frostman	Read Replies (1) \| Respond to of 23519

This from Yahoo thread: Great potential news: by: mercury10001 22831 of 22832 IF Vivus announces a domestic partnership next week expect the following: Based on current valuations all three analysts will upgrade Vivus to a strong buy with 12 month target prices of $20.00/share. This will include: 1)Daine Rauscher 2)Genesis Merchant 3)Cruttendon Roth Also, once CS First Boston ends its investment banking with Vivus is will again actively cover Vivus with a buy rating. If you think this is hype I suggest you call these brokerages before they accumulate all the cheap shares. --------------------------------------------------------------------------------